Your browser doesn't support javascript.
loading
Making Sense of Censored Covariates: Statistical Methods for Studies of Huntington's Disease.
Lotspeich, Sarah C; Ashner, Marissa C; Vazquez, Jesus E; Richardson, Brian D; Grosser, Kyle F; Bodek, Benjamin E; Garcia, Tanya P.
Affiliation
  • Lotspeich SC; Department of Statistical Sciences, Wake Forest University, Winston-Salem, North Carolina, USA.
  • Ashner MC; Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Vazquez JE; Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Richardson BD; Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Grosser KF; Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Bodek BE; Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Garcia TP; Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Annu Rev Stat Appl ; 11: 255-277, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38962579
ABSTRACT
The landscape of survival analysis is constantly being revolutionized to answer biomedical challenges, most recently the statistical challenge of censored covariates rather than outcomes. There are many promising strategies to tackle censored covariates, including weighting, imputation, maximum likelihood, and Bayesian methods. Still, this is a relatively fresh area of research, different from the areas of censored outcomes (i.e., survival analysis) or missing covariates. In this review, we discuss the unique statistical challenges encountered when handling censored covariates and provide an in-depth review of existing methods designed to address those challenges. We emphasize each method's relative strengths and weaknesses, providing recommendations to help investigators pinpoint the best approach to handling censored covariates in their data.
Key words

Full text: 1 Database: MEDLINE Language: En Journal: Annu Rev Stat Appl Year: 2024 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Language: En Journal: Annu Rev Stat Appl Year: 2024 Type: Article Affiliation country: United States